University Department of Rural Health, University of Tasmania, Private Bag, Hobart, TAS, Australia.
BMC Public Health. 2012 Oct 30;12(1):932. doi: 10.1186/1471-2458-12-932.
There is an emerging body of literature suggesting that the evidence-practice divide in health policy is complex and multi-factorial but less is known about the processes by which health policy-makers use evidence and their views about the specific features of useful evidence. This study aimed to contribute to understandings of how the most influential health policy-makers view useful evidence, in ways that help explore and question how the evidence-policy divide is understood and what research might be supported to help overcome this divide.
A purposeful sample of 18 national and state health agency CEOs from 9 countries was obtained. Participants were interviewed using open-ended questions that asked them to define specific features of useful evidence. The analysis involved two main approaches 1)quantitative mapping of interview transcripts using Bayesian-based computational linguistics software 2)qualitative critical discourse analysis to explore the nuances of language extracts so identified.
The decision-making, conclusions-oriented world of policy-making is constructed separately, but not exclusively, by policy-makers from the world of research. Research is not so much devalued by them as described as too technical- yet at the same time not methodologically complex enough to engage with localised policy-making contexts. It is not that policy-makers are negative about academics or universities, it is that they struggle to find complexity-oriented methodologies for understanding their stakeholder communities and improving systems. They did not describe themselves as having a more positive role in solving this challenge than academics.
These interviews do not support simplistic definitions of policy-makers and researchers as coming from two irreconcilable worlds. They suggest that qualitative and quantitative research is valued by policy-makers but that to be policy-relevant health research may need to focus on building complexity-oriented research methods for local community health and service development. Researchers may also need to better explain and develop the policy-relevance of large statistical generalisable research designs. Policy-makers and public health researchers wanting to serve local community needs may need to be more proactive about questioning whether the dominant definitions of research quality and the research funding levers that drive university research production are appropriately inclusive of excellence in such policy-relevant research.
有越来越多的文献表明,健康政策中的证据-实践鸿沟是复杂的、多方面的,但人们对卫生政策制定者如何使用证据以及他们对有用证据的具体特征的看法知之甚少。本研究旨在增进对最有影响力的卫生政策制定者如何看待有用证据的理解,以帮助探索和质疑如何理解证据-政策鸿沟,以及可以支持哪些研究来帮助克服这一鸿沟。
从 9 个国家的 18 名国家和州卫生机构首席执行官中获得了一个有目的的样本。使用开放式问题对参与者进行访谈,要求他们定义有用证据的具体特征。分析涉及两种主要方法:1)使用基于贝叶斯的计算语言学软件对访谈记录进行定量映射;2)进行定性批判话语分析,以探索如此确定的语言提取的细微差别。
政策制定的决策导向、结论导向的世界是由政策制定者与研究人员分别构建的,但并非完全分开。研究并没有被他们贬低,而是被描述为过于技术性的,同时也没有足够的方法学复杂性来与本地化的政策制定背景相联系。并不是政策制定者对学术界或大学持否定态度,而是他们难以找到面向复杂性的方法来理解他们的利益相关者群体并改善系统。他们没有说自己在解决这一挑战方面比学术界有更积极的作用。
这些访谈不支持将政策制定者和研究人员简单地定义为来自两个不可调和的世界。它们表明,政策制定者重视定性和定量研究,但要使健康研究具有政策相关性,可能需要侧重于为当地社区健康和服务发展构建面向复杂性的研究方法。研究人员可能还需要更好地解释和发展具有统计学普遍性的大型研究设计的政策相关性。希望为当地社区需求服务的政策制定者和公共卫生研究人员可能需要更积极地质疑主导的研究质量定义以及推动大学研究成果的研究资金杠杆是否适当包括此类政策相关研究的卓越性。